<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00667680</url>
  </required_header>
  <id_info>
    <org_study_id>01/2007</org_study_id>
    <nct_id>NCT00667680</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant Depression</brief_title>
  <official_title>Transcranial Direct Current Stimulation (tDCS) in Treatment-resistant Depression - Effect on Clinical and Neurophysiological Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      tDCS applies a small amount of direct electric current (DC) to the brain by means of two&#xD;
      electrodes: the one is an active electrode, localized on the effective site, and the other is&#xD;
      a reference electrode, localized on some &quot;silent&quot; part of the body. Anodal transcranial&#xD;
      direct current stimulation (tDCS) of the left dorsolateral prefrontal cortex (DLPFC) has been&#xD;
      associated with working memory enhancement and improvement of mood. This study will&#xD;
      investigate the possible antidepressant effects of tDCS in patients with therapy resistant&#xD;
      major depressive episodes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transcranial direct current stimulation (tDCS) is a non-invasive method that shifts membrane&#xD;
      potential towards hypo- or hyperpolarization and therefore leads to functional changes in a&#xD;
      discrete area of the cerebral cortex.&#xD;
&#xD;
      Neurophysiological studies have shown that slow changes in cortical scalp potential reflect&#xD;
      overall activity of cortical neuronal networks. These scalp potentials reflect shifts in&#xD;
      membrane potentials of the cortical neurons. Over the past 7 years tDCS has evolved as an&#xD;
      important tool to non-invasively manipulate specific neural circuits of the human brain.&#xD;
&#xD;
      The purpose of this study is an investigation of tDCS applied to 20 therapy-resistance major&#xD;
      depressive patients. Our hypothesis is that tDCS may exert an antidepressant effect and/or&#xD;
      enhances the medication effect. tDCS will be examined in the framework of a&#xD;
      placebo-controlled clinical pilot-study investigating effectiveness, safety and influence on&#xD;
      EEG parameters. Patients will receive anodal DC stimulation or sham stimulation (extra&#xD;
      designed placebo-stimulator) in a double-blind design over 10 days for each condition.&#xD;
      Outcomes will be evaluated using several clinical, psychiatric and neuropsychological rating&#xD;
      scales.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hamilton Psychiatric Rating Scale for Depression (HRSD-24)</measure>
    <time_frame>6</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck depression Inventory (BDI) Clinical Global Impression (CGI) Mini-Mental-Status-Test (MMST) Verbal Learning and Memory Test (VLMT) Regensburger Word Fluency Test (RWT)</measure>
    <time_frame>4</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Therapy Resistant Major Depression</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>anodal tDCS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham tDCS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct current stimulation (tDCS) - Eldith DC-Stimulator</intervention_name>
    <description>real or sham tDCS for 20 minutes at 2mA intensity over the left DLPFC (F3 according to the 10-20 system)</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>Eldith DC - Stimulator (neuroConn GmbH, Ilmenau, Germany)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-75 years&#xD;
&#xD;
          -  At least moderate major depressive episode (DSM IV criteria).&#xD;
&#xD;
          -  Stable total pre-treatment Hamilton Rating Scale for Depression score â‰¥18&#xD;
&#xD;
          -  Therapy-resistance during current depressive episode (according to ATHF).&#xD;
&#xD;
          -  The patient must be in the condition to understand the patient-information, as well as&#xD;
             the necessary examinations. He/she must be able to give a written consent.&#xD;
&#xD;
          -  Stable antidepressant medication, that is retained during the study- duration, from at&#xD;
             least three weeks before the begin of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Existence of a care/legal incapacity&#xD;
&#xD;
          -  Existing pregnancy&#xD;
&#xD;
          -  Severe psychiatric illness (with exception of affective disorder)&#xD;
&#xD;
          -  Acute suicidality&#xD;
&#xD;
          -  Drug-, medication- or alcohol dependence&#xD;
&#xD;
          -  Dementia according to DSM IV / ICD 10-criterions&#xD;
&#xD;
          -  Severe TBI in the anamnesis&#xD;
&#xD;
          -  Indications of structural damage of the basal ganglia or the brain stem&#xD;
&#xD;
          -  Severe neurological disorders (e.g. M. Parkinson, epilepsy, discus-prolapse, dementia,&#xD;
             systemic neurological illnesses, normal pressure hydrocephalus, cerebrovascular&#xD;
             diseases, elevated intracranial pressure, in the last 6 months, polyneuropathies).&#xD;
&#xD;
          -  Severe other medical conditions, like manifest arterial hypertonia, severe heart&#xD;
             disease, pacemakers, respiratory failure, malignant illnesses all type, also in the&#xD;
             history, active infectious diseases, skeletal disorders (like M. Paget, osteoporosis&#xD;
             with spontaneous fractures, fresh fractures)&#xD;
&#xD;
          -  Other circumstances, that speaks against a participation of the patient pinion of MD&#xD;
             at this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Padberg, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Psychiatry, Ludwig-Maximilians-University Munich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, Ludwig-Maximilian University Munich</name>
      <address>
        <city>Munich</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://psywifo.klinikum.uni-muenchen.de/forschung/tms/indexeng.html</url>
    <description>Related Info</description>
  </link>
  <verification_date>November 2009</verification_date>
  <study_first_submitted>April 24, 2008</study_first_submitted>
  <study_first_submitted_qc>April 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2008</study_first_posted>
  <last_update_submitted>November 13, 2009</last_update_submitted>
  <last_update_submitted_qc>November 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Frank Padberg, MD, PhD</name_title>
    <organization>Dept. of Psychiatry, Ludwig-Maximilians-University Munich</organization>
  </responsible_party>
  <keyword>tDCS, major depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Depressive Disorder, Treatment-Resistant</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

